<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2020.11057</article-id>
<article-id pub-id-type="publisher-id">mmr-21-06-2415</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening of differentially expressed miRNAs in tensile strain-treated HepG2 cells by miRNA microarray analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Luo</surname><given-names>Xu</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref>
<xref rid="fn1-mmr-21-06-2415" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Shen</surname><given-names>Si</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref>
<xref rid="fn1-mmr-21-06-2415" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Yi</surname><given-names>Suhong</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref>
<xref rid="af2-mmr-21-06-2415" ref-type="aff">2</xref>
<xref rid="fn1-mmr-21-06-2415" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jiangfeng</given-names></name>
<xref rid="af3-mmr-21-06-2415" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Yunchen</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Gao</surname><given-names>Kewei</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Liang</given-names></name>
<xref rid="af1-mmr-21-06-2415" ref-type="aff">1</xref>
<xref rid="c1-mmr-21-06-2415" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-21-06-2415"><label>1</label>Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China</aff>
<aff id="af2-mmr-21-06-2415"><label>2</label>Department of Gastroenterology, Xinyu People&#x0027;s Hospital, Xinyu, Jiangxi 338000, P.R. China</aff>
<aff id="af3-mmr-21-06-2415"><label>3</label>Department of Gastroenterology, Shanghai First People&#x0027;s Hospital, Shanghai 200003, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-21-06-2415"><italic>Correspondence to</italic>: Dr Liang Zhu, Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Huangpu, Shanghai 200003, P.R. China, E-mail: <email>czzhuliang@smmu.edu.cn</email></corresp>
<fn id="fn1-mmr-21-06-2415"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>06</month><year>2020</year></pub-date>
<pub-date pub-type="epub"><day>07</day><month>04</month><year>2020</year></pub-date>
<volume>21</volume>
<issue>6</issue>
<fpage>2415</fpage>
<lpage>2426</lpage>
<history>
<date date-type="received"><day>26</day><month>02</month><year>2019</year></date>
<date date-type="accepted"><day>17</day><month>03</month><year>2020</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Luo et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Cirrhosis and portal hypertension are associated with an increased risk of developing liver cancer. However, it is unknown how changes in the cellular mechanical microenvironment induced by portal hypertension affect the occurrence and development of liver cancer. The aim of this study was to determine the effect of tensile strain on the proliferation of a human liver cancer cell line (HepG2 cells) using methods such as flow cytometry, Cell Counting Kit-8 and 5-bromodeoxyuridine assays, and to examine the changes in microRNA (miRNA/miR) expression using microarray, reverse transcription-quantitative (RT-q)PCR and bioinformatics analyses. It was demonstrated that cyclic tensile force promoted the proliferation of HepG2 cells. The most suitable research conditions were as follows: Tensile strain force loading amplitude 15&#x0025;; frequency 1 Hz; and time 24 h. After loading the HepG2 cells under such conditions, the differentially expressed miRNAs were screened out using an Agilent Human miRNA Microarray, identifying seven miRNAs with significant differences (expression difference &#x003E;2 times and P&#x003C;0.05). A total of five were upregulated, including hsa-miR-296-5p, hsa-miR-6752-5p, hsa-miR-6794-5p, hsa-miR-6889-5p and hsa-miR-7845-5p; and two were downregulated, hsa-miR-4428 and hsa-miR-503-5p. The results of RT-qPCR also further confirmed the expression changes of these miRNAs. Gene Ontology and pathway analyses showed the involvement of these miRNAs in numerous important physiological processes. These findings may provide novel miRNA-based information, thus enhancing the understanding of the pathophysiological processes leading to liver cancer.</p>
</abstract>
<kwd-group>
<kwd>TGF-&#x03B2;</kwd>
<kwd>transforming growth factor &#x03B2;; TIMP1</kwd>
<kwd>tissue inhibitor of metalloproteinases 1; TIMP2</kwd>
<kwd>tissue inhibitor of metalloproteinases 2; miRNAs</kwd>
<kwd>microRNAs; VSMCs</kwd>
<kwd>vascular smooth muscle cells; GO</kwd>
<kwd>Gene Ontology; FDR-bh</kwd>
<kwd>Benjamini-Hochberg false discovery rate; KEGG</kwd>
<kwd>Kyoto Encyclopedia of Genes and Genomes; MAPK</kwd>
<kwd>mitogen-activated protein kinase; DMEM</kwd>
<kwd>Dulbecco&#x0027;s modified Eagle&#x0027;s medium; CCK-8</kwd>
<kwd>Cell Counting Kit-8; BrdU</kwd>
<kwd>5-bromodeoxyuridine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Hepatitis viruses can cause infections that lead to liver cirrhosis, which then increases the risk of liver cancer; thus, hepatitis-cirrhosis-liver cancer is considered to be a &#x2018;trilogy&#x2019; of events (<xref rid="b1-mmr-21-06-2415" ref-type="bibr">1</xref>). Clinical data have shown that most patients with liver cancer had a background of liver fibrosis or cirrhosis (<xref rid="b2-mmr-21-06-2415" ref-type="bibr">2</xref>). In a previous study, the liver stiffness measurement was evaluated in a group of patients with chronic hepatitis C, it was found that the stiffness of the liver could be an independent risk factor for the occurrence of liver cancer (<xref rid="b1-mmr-21-06-2415" ref-type="bibr">1</xref>). It has also been shown that the higher the degree of hepatic fibrosis, the higher the intrahepatic metastasis rate of liver cancer, indicating a significant association between hepatic fibrosis and proliferation, invasion and metastasis of liver cancer cells (<xref rid="b3-mmr-21-06-2415" ref-type="bibr">3</xref>). An <italic>in vivo</italic> experiment, in which liver cancer cells were injected into mice with induced liver fibrosis, demonstrated that liver fibrosis was associated with the development of tumors in these mice (<xref rid="b4-mmr-21-06-2415" ref-type="bibr">4</xref>).</p>
<p>Cirrhosis of the liver can lead to sinusoidal portal hypertension, in which the pressure in the hepatic portal vein increases, which can cause these veins to become significantly dilated (<xref rid="b5-mmr-21-06-2415" ref-type="bibr">5</xref>). Hepatocytes are epithelial cells that line the sinusoids, which are directly and indirectly affected by biomechanical factors, such as the pressure of the hepatic portal vein and the tension strain after the dilation of hepatic sinusoids (<xref rid="b6-mmr-21-06-2415" ref-type="bibr">6</xref>). A number of studies have shown the important roles of biomechanical factors in the regulation of hepatocyte function. Our previous experiments found that mechanical pressure promotes the proliferation, migration and invasion of liver cancer cells (HepG2 and Huh-7) (<xref rid="b7-mmr-21-06-2415" ref-type="bibr">7</xref>). A total of five pressure-responsive microRNAs (miRNAs/miRs) were screened from the results of the mRNA and miRNA microarray, which were uploaded to the Gene Expression Omnibus database (chip nos. GSE119881 and GSE120194). Our previous and present results have both indicated that mechanical stimulation may affect the growth and metastasis of liver cancer (<xref rid="b7-mmr-21-06-2415" ref-type="bibr">7</xref>). Moreover, mechanical stretching has been found to significantly increase the expression of transforming growth factor &#x03B2; (TGF-&#x03B2;) mRNA and related proteins in liver cells (<xref rid="b8-mmr-21-06-2415" ref-type="bibr">8</xref>). In the early stages of portal hypertension, mechanical stretching increased the expression level of matrix metalloproteinase-1 in hepatic stellate cells, reduced the expression levels of tissue inhibitor of metalloproteinases (TIMP)1 and TIMP2, and inhibited the degradation of the extracellular matrix (<xref rid="b9-mmr-21-06-2415" ref-type="bibr">9</xref>). However, the effect of tensile strain on liver cancer cells and its related miRNAs have not yet been reported.</p>
<p>miRNAs are 21-to-23-nucleotide-long noncoding RNA molecules that have important roles in regulating cell proliferation, differentiation and apoptosis (<xref rid="b10-mmr-21-06-2415" ref-type="bibr">10</xref>). Some miRNAs are related to both tensile strain and liver cancer, including miR-29 and miR-21. For example, previous studies demonstrated that the expression of the miR-29 family was downregulated in periodontal ligament cells loaded with tensile strain for 24 h (<xref rid="b11-mmr-21-06-2415" ref-type="bibr">11</xref>) and in liver cancer cells (<xref rid="b12-mmr-21-06-2415" ref-type="bibr">12</xref>). Additionally, the expression of miR-21 in vascular smooth muscle cells (VSMCs) increased significantly after tensile strain loading and in liver cancer tissues (<xref rid="b13-mmr-21-06-2415" ref-type="bibr">13</xref>). These results indicated that certain tension-responsive miRNAs may be important in the development of liver cancer. Therefore, in the present study, the effects of strain force on the proliferation of a human liver cancer cell line (HepG2) were measured by flow cytometry, Cell Counting Kit-8 (CCK-8) and 5-bromodeoxyuridine (BrdU) assays. An Agilent monochromatic marker chip was used to screen differentially expressed miRNAs, and reverse transcription-quantitative (RT-q)PCR was used to verify the results. Gene Ontology (GO) and pathway analyses were used to analyze genes and provide information on how the mechanical microenvironment of liver cancer affects the behavior of liver cancer cells.</p>
<p>The present results suggested that the expression levels of miRNAs in HepG2 cells was significantly changed after loading under the optimal conditions (amplitude of 15&#x0025; at 1 Hz for 24 h). In total, seven differentially expressed miRNAs and 224 target genes were screened. Among them, SMAD7 and SP1 were further examined, with regards to their related functions and mechanisms. GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis suggested that the biological functions of the target genes were mainly related to various cancer types, including TGF-&#x03B2;/mitogen-PI3K/Akt and other signaling pathways, closely related to different cancer types. Moreover, the possible mechanism was identified to be via the regulation of SMAD7 and TGF-&#x03B2; signaling pathway by hsa-miR-503-5p.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture</title>
<p>HepG2 cells were purchased from American Type Culture Collection (cat. no. HB 8065). HL-7702 cells were purchased from cell bank of typical culture preservation Committee of Chinese Academy of Sciences. The cells were cultured at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub> in Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM; Jiangsu Kaiji Biotechnology Co., Ltd.) containing 10&#x0025; fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) for different durations (2, 6, 12, 24 and 48 h). The cell line was authenticated by short tandem repeat analysis.</p>
</sec>
<sec>
<title>Cyclic stretching device</title>
<p>In this experiment, the FX-4000T&#x2122; Tension system (Flexcell International Corporation) purchased by the Biomechanics Laboratory of Shanghai Jiao Tong University was used. The tensile strain principle of the device was to use a vacuum pump to draw air, make space under an elastic film in the vacuum environment and produce downward tension strain. When the vacuum pump was relaxed, the elastic membrane retracted under its own elastic force and circulated, thus producing periodic tensile strain (<xref rid="b14-mmr-21-06-2415" ref-type="bibr">14</xref>).</p>
</sec>
<sec>
<title>BioFlex amino-culture plate coating</title>
<p>Numerous routine treatment methods were tested in the laboratory, such as soaking in hydrochloric acid (plate) for 24 h, followed by soaking in water for 24 h, then drying, gelatin coating or cleaning. Moreover, drying after soaking in 75&#x0025; alcohol for 24 h, then gelatin coating was performed. However, when using these methods cells did not adherent to the wells and grew poorly. Later, the plate was washed and dried. Then, the gelatin was changed into rat tail collagen for coating, it was found that the cells could adhere to the wall and grow efficiently. The BioFlex amino-culture plates (Flexcell International Corporation) were coated with 2 mg/ml rat tail collagen solution (Roche Diagnostics). Then, 20 &#x00B5;l of collagen solution was added to each well and smeared evenly with an aseptic cell scraper. Subsequently, the plates were blow-dried on a clean bench and irradiated with ultraviolet light for 1 h.</p>
</sec>
<sec>
<title>Cyclic stretch application</title>
<p>The cells were seeded on BioFlex amino-culture plates at a density of 1&#x00D7;10<sup>5</sup> cells/well. After 24 h, the culture medium was replaced with serum-free medium for another 24 h to synchronize the cells in 37&#x00B0;C incubator. The cells in the serum-free medium were then exposed to cyclic stretch provided by the FX-4000T Tension system.</p>
</sec>
<sec>
<title>Flow cytometry analysis</title>
<p>In the periodic strain-loaded cells, three main parameters were used; these were tensile strain amplitude, tension strain frequency and time. By fixing two of the parameters, the other parameter was changed to observe the effect of tension strain on HepG2 cells (except these three parameters, all the other experimental conditions were the same). After synchronizing HepG2 cells implanted on BioFlex amino-culture plates for 24 h, three groups of experiments were set up: i) Tension strain time (tensile strain frequency fixed to 1 Hz; amplitude to 15&#x0025;; and tension strain time set to 2, 6, 12, 24 or 48 h, a total of five experimental groups); ii) tensional strain frequency (tensile strain time fixed to 24 h; amplitude to 15&#x0025;; and tensile strain frequency set to 0.5 and 1 Hz, a total of two experimental groups); and iii) tensile strain amplitude (tensile strain time fixed to 24 h; frequency to 1 Hz; and tensile strain amplitude set to 5 and 15&#x0025;, a total of two experimental groups). All the control groups were nontension loaded groups. After tension loading, the cells were digested with trypsin (containing EDTA; Jiangsu Kaiji Biotechnology Co., Ltd.), resuspended with 0.5 ml 1X PBS containing 50 &#x00B5;g/ml propidium iodide (PI) and 200 &#x00B5;g/ml ribonuclease (Roche Diagnostics) and incubated at 37&#x00B0;C for 30 min. PI is an insertion nucleic acid fluorescent dye; its binding amount is proportional to the content of DNA in the cell. Using flow cytometry and FlowJo V10 software (FlowJo LLC) DNA distribution status at various stages of the cell cycle can be obtained, and the percentage of each cell cycle can be calculated. After propidium iodide staining, if the fluorescence intensity of G0/G1 phase cells is 1, the theoretical value of the fluorescence intensity of G2/M phase cells that contain double genomic DNA is 2, and the fluorescence intensity of S phase cells undergoing DNA replication is 1&#x2013;2 (<xref rid="b15-mmr-21-06-2415" ref-type="bibr">15</xref>). Then, flow cytometry was used to detect the cell cycle with a standard program. In the analysis, the proliferation index (PI) = (S &#x002B; G2/M) / (G0/G1 &#x002B; S &#x002B; G2/M) was used to evaluate the effect of different tensile strain loading conditions on cell proliferation, and the ideal tension strain conditions for HepG2 cells were determined. The experiment was repeated three times.</p>
</sec>
<sec>
<title>BrdU assay</title>
<p>The HepG2 cells and HL-7702 cells seeded on the BioFlex amino-culture plates were synchronized for 24 h and then connected to the Flexcell FX-4000T Tension system. The experimental group was treated for 24 h with a tensile strain amplitude of 15&#x0025; and a frequency of 1 Hz, while the control group was the non-tension loaded group. BrdU (2 &#x00B5;l/well; Sigma-Aldrich; Merck KGaA) was added to the tension strain and control groups simultaneously at 8 h before the end of the tension strain treatment in the 37&#x00B0;C incubator. At the end of the strain, the cells were collected by trypsin digestion, and the cell concentration was adjusted to 1&#x00D7;10<sup>5</sup>/ml in DMEM (containing 10&#x0025; FBS). The cells were cultured on the 96-cell plate (100 &#x00B5;l of cell suspensions/well) at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub> for 4 h until they adhered. Finally, the medium was dried and put in a 4&#x00B0;C refrigerator overnight. Furthermore, FixDenat solution (200 &#x00B5;l/well; Sigma-Aldrich; Merck KGaA) was added and incubated for 30 min at room temperature. The anti-BrdU-Peroxidase storage solution was diluted 100 times with antibody diluent, added to the cells (100 &#x00B5;l/well) and incubated at room temperature for 90 min. The supernatant was removed, and PBS was used to wash the cells three times. Next, tetramethylbenzidine substrate (100 &#x00B5;l/well; Sigma-Aldrich; Merck KGaA) was added at room temperature for 5&#x2013;30 min to complete color development. Subsequently, sulfuric acid (1 M) was added to terminate the reaction immediately (25 &#x00B5;l/well). The 96-cell plate was vibrated for 60 sec and the absorbance was measured at 450 nm using a microplate reader (Bio-Rad Laboratories, Inc.), with a reference wavelength of 630 nm.</p>
</sec>
<sec>
<title>CCK-8 assay</title>
<p>The HepG2 cells seeded on the BioFlex amino-culture plates were synchronized for 24 h and then connected to the Flexcell FX-4000T Tension system. The experimental group was treated for 24 h with a tensile strain amplitude of 15&#x0025; and a frequency of 1 Hz, while the control group was the nontension loaded group. Then, 0.5 h before the end of the tension strain treatment, CCK-8 reagent (Sangon Biotech, Co., Ltd.) was added to the tension strain and control groups at the same time (200 &#x00B5;l/well), and the assay was operated according to the manufacturer&#x0027;s protocols. After the tension strain treatment, the cell culture medium in each well was transferred into a 96-well plate. Subsequently, the 96-cell plate was put in the microplate reader (Bio-Rad Laboratories, Inc.). After vibration for 60 sec, the absorbance at 450 nm was measured, with a reference wavelength of 630 nm.</p>
</sec>
<sec>
<title>miRNA expression analysis using a miRNA array</title>
<p>Total RNA was extracted by TRIzol<sup>&#x00AE;</sup> reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer&#x0027;s protocol, purified using miRNeasy Mini kit (Qiagen GmbH) and quantified using the NanoDrop&#x2122; 2000 (Thermo Fisher Scientific, Inc.), and the RNA integrity was assessed using an Agilent 2100 Bioanalyzer instrument (Agilent Technologies, Inc.). The sample labeling, microarray hybridization and washing were performed based on the manufacturer&#x0027;s standard protocols. Differentially expressed miRNAs were then identified based on fold-change and P-value, as calculated using the t-test. The threshold set for up- and downregulated genes was a fold-change &#x2265;2.0 and P&#x003C;0.05.</p>
</sec>
<sec>
<title>RT-qPCR</title>
<p>RT-qPCR was performed to validate the microarray data. The extracted total RNAs were reverse transcribed using Moloney Murine Leukemia Virus reverse transcriptase (Thermo Fisher Scientific, Inc.) with a special stem-loop primer (RT primer). The thermocycling conditions were as follows: 42&#x00B0;C for 1 h, followed by 70&#x00B0;C for 5 min. Then, RT-qPCR was performed with a SYBR Green PCR kit (Takara Bio, Inc.) on an ABI PRISM 7500 Real-time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) according to the manufacturer&#x0027;s protocols. The thermocycling conditions were as follows: Initial denaturation at 95&#x00B0;C for 15 min, followed by 40 cycles at 62&#x00B0;C for 40 sec, 95&#x00B0;C for 1 min and 55&#x00B0;C for 1 min. The sequences of RT and PCR primers are listed in <xref rid="tI-mmr-21-06-2415" ref-type="table">Table I</xref>. The expression levels of miRNAs were normalized to U6 expression. miRNA expression levels were calculated using the 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method (<xref rid="b16-mmr-21-06-2415" ref-type="bibr">16</xref>).</p>
</sec>
<sec>
<title>Target genes of differentially expressed miRNAs</title>
<p>Target genes of differentially expressed miRNAs were determined as the intersection of the predictions of the three databases: TargetScan V7.2 (<uri xlink:href="http://www.targetscan.org/">http://www.targetscan.org/</uri>), <uri xlink:href="http://microRA.org">microRA.org</uri> (<uri xlink:href="http://www.microrna.org">http://www.microrna.org</uri>; November 2010 version) and PITA (<uri xlink:href="https://genie.weizmann.ac.il/">https://genie.weizmann.ac.il/</uri>) (<xref rid="b17-mmr-21-06-2415" ref-type="bibr">17</xref>). All data were obtained from the databases in January 2019.</p>
</sec>
<sec>
<title>GO and pathway analyses of predicted mRNA targets</title>
<p>GO analysis (<uri xlink:href="http://geneontology.org/docs/go-citation-policy/">http://geneontology.org/docs/go-citation-policy/</uri>) and pathway analysis were performed on predicted mRNA targets of miRNAs using Database for Annotation, Visualization, and Integrated Discovery (<xref rid="b18-mmr-21-06-2415" ref-type="bibr">18</xref>) and KEGG database (<xref rid="b19-mmr-21-06-2415" ref-type="bibr">19</xref>,<xref rid="b20-mmr-21-06-2415" ref-type="bibr">20</xref>), respectively. Specific biological process categories and pathways were enriched. The threshold of significance was defined by P&#x003C;0.05 and Benjamini-Hochberg (<xref rid="b21-mmr-21-06-2415" ref-type="bibr">21</xref>) false discovery rate (FDR-bh) &#x003C;0.25.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Statistical analysis was performed using GraphPad Prism 6 software (GraphPad Software, Inc.). Each experiment was performed at least three times, and all values were expressed as the mean &#x00B1; standard deviation. Data from &#x2265;3 were analyzed using one-way ANOVA followed by Fisher&#x0027;s Least Significant Difference or Dunnett&#x0027;s post hoc comparison test as applicable. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>BioFlex amino-culture plate coating</title>
<p>Due to the lack of related reports on HepG2 cells cultured on BioFlex plates, several methods were tried in this experiment. Finally, type I rat tail collagen was selected. The results showed that type I rat tail collagen coating led to increased cell adherence and growth of HepG2 cells in the BioFlex plates (<xref rid="f1-mmr-21-06-2415" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>Using flow cytometry to determine the most suitable strain condition</title>
<p>i) Tension strain time: The PI increased significantly in 24 and 48 h groups compared with the control group without tension (P&#x003C;0.0001; <xref rid="f2-mmr-21-06-2415" ref-type="fig">Fig. 2A and B</xref>). ii) Tensional strain frequency: The PI increased significantly in the 1 Hz group compared with the control group without tension (P&#x003C;0.001; <xref rid="f2-mmr-21-06-2415" ref-type="fig">Fig. 2C and D</xref>). iii) Tensile strain amplitude: The PI increased significantly in the 15&#x0025; group compared with the control group without tension (P&#x003C;0.0001; <xref rid="f2-mmr-21-06-2415" ref-type="fig">Fig. 2E and F</xref>).</p>
<p>Based on the experimental results of the aforementioned three groups of tensile strain loading conditions, a tensile strain amplitude of 15&#x0025;, frequency of 1 Hz and time of 24 h were selected as the ideal conditions for the following experiments.</p>
</sec>
<sec>
<title>Proliferation of liver cancer cells is promoted by tensor strain</title>
<p>The results of the BrdU assay showed that the tensile strain amplitude of 15&#x0025; at 1 Hz for 24 h significantly promoted DNA synthesis in cells compared with the control group (P&#x003C;0.001; <xref rid="f3-mmr-21-06-2415" ref-type="fig">Fig. 3A</xref>). Additionally, the CCK-8 assay also demonstrated that these conditions significantly promoted DNA synthesis in the cells (P&#x003C;0.0001; <xref rid="f3-mmr-21-06-2415" ref-type="fig">Fig. 3B</xref>). Thus, this indicated that tensile strain could lead to increased liver cancer cell proliferation.</p>
</sec>
<sec>
<title>Differentially expressed miRNAs in response to tensile strain</title>
<p>To investigate the effects of tensile strain on the miRNA profile of HepG2 cells, tensile strain was applied to the activated HepG2 cells, and RNA was extracted and subjected to microarray analysis. As shown in <xref rid="tII-mmr-21-06-2415" ref-type="table">Table II</xref>, seven significantly differentially expressed miRNAs showed a fold-change threshold of &#x2265;2.0 and P&#x003C;0.05. Of these seven miRNAs in the tensile strain-treated group, five were upregulated (hsa-miR-296-5p, hsa-miR-6752-5p, hsa-miR-6794-5p, hsa-miR-6889-5p and hsa-miR-7845-5p) and two were downregulated (hsa-miR-4428 and hsa-miR-503-5p) compared with the control group.</p>
</sec>
<sec>
<title>Validation of miRNA microarray with RT-qPCR</title>
<p>RT-qPCR was performed to validate the microarray results of the five upregulated and two downregulated miRNAs. As shown in <xref rid="f4-mmr-21-06-2415" ref-type="fig">Fig. 4</xref>, the changes in the seven miRNAs detected by RT-qPCR were consistent with those of the miRNA microarray.</p>
</sec>
<sec>
<title>GO and KEGG pathway analyses</title>
<p>Potential target genes for the aforementioned seven differentially expressed miRNAs were searched using three bioinformatics databases, miRNAorg, PITA and TargetScan, which predicted 2,306, 1,277 and 16,205 target genes, respectively. The false results were removed by taking the intersection of the results from the three databases for 224 target genes (<xref rid="f5-mmr-21-06-2415" ref-type="fig">Fig. 5</xref>). The 16,205 predictive target genes refer to the sum of all seven predictive target genes that differentially express miRNAs. The components are shown in the <xref rid="tIII-mmr-21-06-2415" ref-type="table">Table III</xref>.</p>
<p>GO and pathway analyses were used to understand the biological characteristics of the aforementioned target genes. Using a threshold of FDR-bh &#x003C;0.25, 132 GO terms were considered to be significant. Additionally, 6, 25 and 101 GO terms belonged to the &#x2018;cellular component&#x2019; category (<xref rid="f6-mmr-21-06-2415" ref-type="fig">Fig. 6A</xref>), &#x2018;molecular function&#x2019; category (<xref rid="f6-mmr-21-06-2415" ref-type="fig">Fig. 6B</xref>) and &#x2018;biological process&#x2019; category (<xref rid="f6-mmr-21-06-2415" ref-type="fig">Fig. 6C</xref>), respectively. The x-axis of <xref rid="f6-mmr-21-06-2415" ref-type="fig">Fig. 6</xref> shows the P-value corrected by FDR-bh algorithm, which is converted by -log10. The longer the column is, the higher the enrichment degree is. The target genes were concentrated in &#x2018;cyclin-dependent protein kinase holoenzyme complex&#x2019;, &#x2018;neuromuscular junction&#x2019;, &#x2018;microtubule cytoskeleton&#x2019;, &#x2018;protein kinase binding&#x2019;, &#x2018;protein binding&#x2019;, &#x2018;positive regulation of transcription from RNA polymerase II promoter&#x2019;, &#x2018;positive regulation of transcription, DNA-templated&#x2019;, &#x2018;negative regulation of cell migration&#x2019;, &#x2018;positive regulation of skeletal muscle tissue development&#x2019; and &#x2018;patterning of blood vessel&#x2019; categories.</p>
<p>Using KEGG pathway analysis, 52 significant KEGG pathways were identified at a cutoff FDR-bh &#x003C;0.25. These pathways included diseases, such as &#x2018;breast cancer&#x2019;, &#x2018;melanoma&#x2019;, &#x2018;prostate cancer&#x2019;, &#x2018;endocrine resistance&#x2019; and &#x2018;bladder cancer&#x2019;, and signaling pathways, such as &#x2018;mitogen-activated protein kinase (MAPK) signaling pathway&#x2019;, &#x2018;PI3K-Akt signaling pathway&#x2019;, &#x2018;forkhead box O signaling pathway&#x2019; and &#x2018;Ras signaling pathway&#x2019; (<xref rid="f6-mmr-21-06-2415" ref-type="fig">Fig. 6D</xref>).</p>
</sec>
<sec>
<title>Strain has no effect on the proliferation of normal liver cells</title>
<p>Using BrdU experiments, it was demonstrated that the proliferative ability of HepG2 cells after tension intervention was significantly improved (P&#x003C;0.05), while the proliferative ability of normal hepatocyte HL-7702 did not change significantly (<xref rid="f7-mmr-21-06-2415" ref-type="fig">Fig. 7</xref>).</p>
<p>Flexcell-5000T was also used to performed traction experiments on Huh-7 cells and MHCC97H cells, but the two cells could not adhere to the membrane on the traction plate, and thus HepG2 cells were selected for subsequent experimentation.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Human liver cancer cells grow in a complex internal environment where the mechanical factors should not be ignored. The present study demonstrated that tensile strain promoted the growth of liver cancer cells and accelerated their proliferation. To some extent, this could explain why cirrhosis can significantly increase the occurrence and development of liver cancer, but the exact underlying mechanism is still unclear. It has been suggested that other biomechanical forces, such as fluid shear stress, may affect the cytoskeleton of liver cancer cells (<xref rid="b22-mmr-21-06-2415" ref-type="bibr">22</xref>). Subsequently, this fluid shear stress could activate signaling pathways, affect the gene expression and influence cellular features (<xref rid="b23-mmr-21-06-2415" ref-type="bibr">23</xref>). Numerous studies have shown that strain can promote the proliferation of various types of cells, such as VSMCs (<xref rid="b24-mmr-21-06-2415" ref-type="bibr">24</xref>), osteoblasts (<xref rid="b25-mmr-21-06-2415" ref-type="bibr">25</xref>) and dermal keratinocytes (<xref rid="b26-mmr-21-06-2415" ref-type="bibr">26</xref>). In the present study, type I rat tail collagen was chosen to coat BioFlex plates for effective adherence and cell growth. Then, suitable tensile strain loading conditions were identified for human liver cancer cell line HepG2, and seven differentially expressed miRNAs were screened after tensile strain loading.</p>
<p>Previous studies have shown that miR-296-5p is upregulated and plays a role in the progression of various tumors, such as esophageal and laryngeal cancer (<xref rid="b27-mmr-21-06-2415" ref-type="bibr">27</xref>&#x2013;<xref rid="b29-mmr-21-06-2415" ref-type="bibr">29</xref>). Additionally, it is also overexpressed in a number of tumor cells and induces carcinogenesis in human cells by downregulating the p53-p21 (wild-type p53 activated fragment 1) pathway (<xref rid="b30-mmr-21-06-2415" ref-type="bibr">30</xref>). It has been demonstrated that miR-6889-5p has a catalytic role in type 1 autoimmune liver disease (<xref rid="b31-mmr-21-06-2415" ref-type="bibr">31</xref>). It can also inhibit the proliferation of human cells (<xref rid="b32-mmr-21-06-2415" ref-type="bibr">32</xref>). miR-4428 is associated with malignant B-cell lymphoma (<xref rid="b33-mmr-21-06-2415" ref-type="bibr">33</xref>). These previous results suggest that a number of differentially expressed miRNAs are closely related to the development of cancer.</p>
<p>In the present study, it was shown that miR-503-5p was downregulated in tensile strain-treated HepG2 cells. Previous reports have indicated that miR-503-5p is related to the proliferation and invasion of various cancer cells. For example, as a cell migration and invasion suppressor, miR-503-5p can inhibit the metastasis of ovarian cancer cells by inhibiting the CD97-mediated Janus kinase 2/STAT3 pathway (<xref rid="b34-mmr-21-06-2415" ref-type="bibr">34</xref>). It was recently found to inhibit cell epithelial-to-mesenchymal transition and metastasis of liver cancer by inhibiting WEE1 G2 checkpoint kinase, thus predicting the prognosis of liver cancer (<xref rid="b35-mmr-21-06-2415" ref-type="bibr">35</xref>). As a cell proliferation suppressor, miR-503-5p inhibited the proliferation of T24 and EJ bladder cancer cells by interfering with the retinoblastoma gene/E2F signaling pathway (<xref rid="b36-mmr-21-06-2415" ref-type="bibr">36</xref>). However, whether miR-503-5p affects the growth of liver cancer cells by regulating their proliferation has not yet been reported, and it is worth further study. It is worth noting that SMAD7, as one of the target genes of miR-503-5p, is closely related to the expression of TGF-&#x03B2;. TGF-&#x03B2; is a key factor in the process of hepatic fibrosis (<xref rid="b8-mmr-21-06-2415" ref-type="bibr">8</xref>). Previous studies have demonstrated that SMAD7 has roles in various types of cancer; it is overexpressed in endometrial carcinoma (<xref rid="b37-mmr-21-06-2415" ref-type="bibr">37</xref>), it can enhance the tumorigenicity of pancreatic cancer (<xref rid="b38-mmr-21-06-2415" ref-type="bibr">38</xref>) and it is closely associated with colon cancer (<xref rid="b39-mmr-21-06-2415" ref-type="bibr">39</xref>). miR-92b (<xref rid="b40-mmr-21-06-2415" ref-type="bibr">40</xref>) and long noncoding RNA snail family zinc finger 3-antisense 1 (<xref rid="b41-mmr-21-06-2415" ref-type="bibr">41</xref>) could promote liver cancer proliferation and metastasis by targeting SMAD7. These results suggested that mechanical factors may have a biological role by regulating the expression of SMAD7 gene in the development of liver cancer. The specific mechanism underlying this process needs to be identified and studied further.</p>
<p>To understand the specific function of the differentially expressed miRNAs, the target mRNAs of the differentially expressed miRNAs were also analyzed by GO analysis. The results showed that the target mRNAs were involved in numerous physiological processes, including &#x2018;cyclin-dependent protein kinase holoenzyme complex&#x2019;, which could indicate that they may exert an anticancer effect by inhibiting the effect of this complex (<xref rid="b42-mmr-21-06-2415" ref-type="bibr">42</xref>). Furthermore, the genes were enriched in &#x2018;transcription factor complex&#x2019;, &#x2018;positive regulation of transcription from RNA polymerase II promoter&#x2019; and &#x2018;positive regulation of transcription, DNA templated&#x2019;, which are also related to the DNA transcription and RNA translation of the cells, indicating that the function of miRNAs is closely related to the proliferation and viability of cancer cells. Also, enrichment in &#x2018;patterning of blood vessels&#x2019; may be associated with tumor cells stimulating angiogenesis to provide nutrition. To reveal the regulation of pathways by these miRNAs, KEGG pathway analysis was performed based on the predicted target mRNAs of these miRNAs. Notably, some pathways related to cancers, such as &#x2018;breast cancer&#x2019;, &#x2018;melanoma&#x2019;, &#x2018;prostate cancer&#x2019; and &#x2018;bladder cancer&#x2019;, were identified as significant. The significant &#x2018;MAPK signaling pathway&#x2019; has been reported to be associated with multiple cancers (<xref rid="b43-mmr-21-06-2415" ref-type="bibr">43</xref>&#x2013;<xref rid="b45-mmr-21-06-2415" ref-type="bibr">45</xref>). Also, &#x2018;PI3K-Akt signaling pathway&#x2019; components were found to be frequently altered in human cancers (<xref rid="b46-mmr-21-06-2415" ref-type="bibr">46</xref>). The results suggested that these pathways might be involved in the proliferation and development of liver cancer, but the specific mechanisms need to be further explored.</p>
<p>In conclusion, a series of changes in tensile strain-treated HepG2 cells were explored in this study. Tensile strain was found to promote the proliferation of HepG2 cell line. Some differentially expressed miRNAs were screened, and their possible target genes and related pathways were preliminarily discussed. There were two major limitations of this research. The first one is that only a single cell line was used in this study. The second is that no experiments were performed to confirm these findings with liver cancer tissues, such as small RNA-seq datasets of low degree hepatic fibrosis and a high degree of hepatic fibrosis liver cancer samples. The follow-up studies may need to be completed by other research groups. The findings could provide new information for the study of carcinogenesis and development of liver cancer and contribute to improving the outcomes for patients with liver cancer.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>This study was funded by the National Natural Science Foundation of China (grant no. 11472300).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>XL, SS, SY and LZ conceived the study, performed the research and wrote the first draft. JH, YS, KG and LZ collected and analyzed the data. All authors contributed to the design and interpretation of the study, and to further drafts. LZ was the guarantor and made substantial contributions to conception and design of the study, and the interpretation of data. LZ supervised and reviewed the results of the experiment and all aspects of the research work and revised the content of the manuscript prior to submission. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec>
<title>Authors&#x0027; information</title>
<p>LZ is a professor of the Second Affiliated Hospital of the Second Military Medical University, a member of the Shanghai Biomechanics Professional Committee and a peer-reviewed expert of the National Natural Science Foundation of China (NSFC). His main research direction is biomechanical study of digestive system diseases and tumors, with emphasis on liver hemodynamics and gastrointestinal dynamics. For numerous years, our team performed research into the hemodynamics of portal hypertension before and after TIPS, and completed the NSFC project: The role and mechanism of microRNAs in the biomechanical response of hepatic stellate cells. The research reported by this manuscript is one part of another NSFC project: The role of microRNAs regulating the differentiation and invasion of liver cancer in response to mechanical force.</p>
</sec>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>miRNA</term><def><p>HepG2, tensile strain, liver cancer, mechanotransduction</p></def></def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="b1-mmr-21-06-2415"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuzaki</surname><given-names>R</given-names></name><name><surname>Tateishi</surname><given-names>R</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>E</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Ohki</surname><given-names>T</given-names></name><name><surname>Imamura</surname><given-names>J</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Kanai</surname><given-names>F</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prospective risk assessment for liver cancer development in patients with chronic hepatitis C by transient elastography</article-title><source>Hepatology</source><volume>49</volume><fpage>1954</fpage><lpage>1961</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/hep.22870</pub-id><pub-id pub-id-type="pmid">19434742</pub-id></element-citation></ref>
<ref id="b2-mmr-21-06-2415"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattovich</surname><given-names>G</given-names></name><name><surname>Stroffolini</surname><given-names>T</given-names></name><name><surname>Zagni</surname><given-names>I</given-names></name><name><surname>Donato</surname><given-names>F</given-names></name></person-group><article-title>Hepatocellular carcinoma in cirrhosis: Incidence and risk factors</article-title><source>Gastroenterology</source><volume>127</volume><supplement>(Suppl 1)</supplement><fpage>S35</fpage><lpage>S50</lpage><year>2004</year><pub-id pub-id-type="doi">10.1053/j.gastro.2004.09.014</pub-id><pub-id pub-id-type="pmid">15508101</pub-id></element-citation></ref>
<ref id="b3-mmr-21-06-2415"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osada</surname><given-names>S</given-names></name><name><surname>Kanematsu</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Goshima</surname><given-names>S</given-names></name><name><surname>Sugiyama</surname><given-names>Y</given-names></name></person-group><article-title>Hepatic fibrosis influences the growth of liver cancer</article-title><source>Hepatogastroenterology</source><volume>55</volume><fpage>184</fpage><lpage>187</lpage><year>2008</year><pub-id pub-id-type="pmid">18507103</pub-id></element-citation></ref>
<ref id="b4-mmr-21-06-2415"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornek</surname><given-names>M</given-names></name><name><surname>Raskopf</surname><given-names>E</given-names></name><name><surname>Tolba</surname><given-names>R</given-names></name><name><surname>Becker</surname><given-names>U</given-names></name><name><surname>Kl&#x00F6;ckner</surname><given-names>M</given-names></name><name><surname>Sauerbruch</surname><given-names>T</given-names></name><name><surname>Schmitz</surname><given-names>V</given-names></name></person-group><article-title>Accelerated orthotopic liver cancers growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis</article-title><source>Liver Int</source><volume>28</volume><fpage>509</fpage><lpage>518</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1478-3231.2008.01670.x</pub-id><pub-id pub-id-type="pmid">18339078</pub-id></element-citation></ref>
<ref id="b5-mmr-21-06-2415"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>JF</given-names></name><name><surname>Liu</surname><given-names>BH</given-names></name><name><surname>Wu</surname><given-names>CQ</given-names></name><name><surname>Yu</surname><given-names>HY</given-names></name><name><surname>Yao</surname><given-names>DK</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name></person-group><article-title>miR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1</article-title><source>World J Gastroenterol</source><volume>21</volume><fpage>9900</fpage><lpage>9915</lpage><year>2015</year><pub-id pub-id-type="doi">10.3748/wjg.v21.i34.9900</pub-id><pub-id pub-id-type="pmid">26379395</pub-id><pub-id pub-id-type="pmcid">4566383</pub-id></element-citation></ref>
<ref id="b6-mmr-21-06-2415"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name></person-group><article-title>Identification of miRNAs associated with the mechanical response of hepatic stellate cells by miRNA microarray analysis</article-title><source>Exp Ther Med</source><volume>16</volume><fpage>1707</fpage><lpage>1714</lpage><year>2018</year><pub-id pub-id-type="pmid">30186391</pub-id><pub-id pub-id-type="pmcid">6122293</pub-id></element-citation></ref>
<ref id="b7-mmr-21-06-2415"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name></person-group><article-title>Identification and integrative analysis of microRNAs and mRNAs involved in proliferation and invasion of pressure treated human liver cancer cell lines</article-title><source>Mol Med Rep</source><volume>20</volume><fpage>375</fpage><lpage>387</lpage><year>2019</year><pub-id pub-id-type="pmid">31115518</pub-id><pub-id pub-id-type="pmcid">6580022</pub-id></element-citation></ref>
<ref id="b8-mmr-21-06-2415"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>R</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Ueno</surname><given-names>H</given-names></name><name><surname>Sata</surname><given-names>M</given-names></name></person-group><article-title>Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells</article-title><source>Eur J Clin Invest</source><volume>34</volume><fpage>129</fpage><lpage>136</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1365-2362.2004.01302.x</pub-id><pub-id pub-id-type="pmid">14764076</pub-id></element-citation></ref>
<ref id="b9-mmr-21-06-2415"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Mikami</surname><given-names>KI</given-names></name><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Ohshima</surname><given-names>S</given-names></name><name><surname>Yoneyama</surname><given-names>K</given-names></name><name><surname>Nakane</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>D</given-names></name><name><surname>Otaka</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name></person-group><article-title>Mechanical stretch induces matrix metalloproteinase 1 production in human hepatic stellate cells</article-title><source>Pathophysiology</source><volume>11</volume><fpage>153</fpage><lpage>158</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.pathophys.2004.07.003</pub-id><pub-id pub-id-type="pmid">15561512</pub-id></element-citation></ref>
<ref id="b10-mmr-21-06-2415"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozomara</surname><given-names>A</given-names></name><name><surname>Birgaoanu</surname><given-names>M</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S</given-names></name></person-group><article-title>miRBase: From microRNA sequences to function</article-title><source>Nucleic Acids Res</source><volume>47</volume><issue>D1</issue><fpage>D155</fpage><lpage>D162</lpage><year>2019</year><pub-id pub-id-type="doi">10.1093/nar/gky1141</pub-id><pub-id pub-id-type="pmid">30423142</pub-id></element-citation></ref>
<ref id="b11-mmr-21-06-2415"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Mohammed</surname><given-names>A</given-names></name><name><surname>Oubaidin</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>CA</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Luan</surname><given-names>X</given-names></name><name><surname>Diekwisch</surname><given-names>TG</given-names></name><name><surname>Atsawasuwan</surname><given-names>P</given-names></name></person-group><article-title>Cyclic stretch and compression forces alter microRNA-29 expression of human periodontal ligament cells</article-title><source>Gene</source><volume>566</volume><fpage>13</fpage><lpage>17</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.gene.2015.03.055</pub-id><pub-id pub-id-type="pmid">25827718</pub-id></element-citation></ref>
<ref id="b12-mmr-21-06-2415"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parpart</surname><given-names>S</given-names></name><name><surname>Roessler</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>F</given-names></name><name><surname>Rao</surname><given-names>V</given-names></name><name><surname>Takai</surname><given-names>A</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>LX</given-names></name><name><surname>Ye</surname><given-names>QH</given-names></name><name><surname>Jia</surname><given-names>HL</given-names></name><name><surname>Tang</surname><given-names>ZY</given-names></name><etal/></person-group><article-title>Modulation of miR-29 expression by &#x03B1;-fetoprotein is linked to the liver cancer epigenome</article-title><source>Hepatology</source><volume>60</volume><fpage>872</fpage><lpage>883</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/hep.27200</pub-id><pub-id pub-id-type="pmid">24798303</pub-id><pub-id pub-id-type="pmcid">4146718</pub-id></element-citation></ref>
<ref id="b13-mmr-21-06-2415"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladeiro</surname><given-names>Y</given-names></name><name><surname>Couchy</surname><given-names>G</given-names></name><name><surname>Balabaud</surname><given-names>C</given-names></name><name><surname>Bioulac-Sage</surname><given-names>P</given-names></name><name><surname>Pelletier</surname><given-names>L</given-names></name><name><surname>Rebouissou</surname><given-names>S</given-names></name><name><surname>Zucman-Rossi</surname><given-names>J</given-names></name></person-group><article-title>MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations</article-title><source>Hepatology</source><volume>47</volume><fpage>1955</fpage><lpage>1963</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/hep.22256</pub-id><pub-id pub-id-type="pmid">18433021</pub-id></element-citation></ref>
<ref id="b14-mmr-21-06-2415"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderploeg</surname><given-names>EJ</given-names></name><name><surname>Imler</surname><given-names>SM</given-names></name><name><surname>Brodkin</surname><given-names>KR</given-names></name><name><surname>Garc&#x00ED;a</surname><given-names>AJ</given-names></name><name><surname>Levenston</surname><given-names>ME</given-names></name></person-group><article-title>Oscillatory tension differentially modulates matrix metabolism and cytoskeletal organization in chondrocytes and fibrochondrocytes</article-title><source>J Biomech</source><volume>37</volume><fpage>1941</fpage><lpage>1952</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.jbiomech.2004.02.048</pub-id><pub-id pub-id-type="pmid">15519602</pub-id></element-citation></ref>
<ref id="b15-mmr-21-06-2415"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>P</given-names></name></person-group><article-title>DNA Analysis by Flow Cytometry</article-title><source>Flow Cytometry</source><person-group person-group-type="editor"><name><surname>Macey</surname><given-names>MG</given-names></name></person-group><publisher-name>Humana Press</publisher-name><fpage>165</fpage><lpage>179</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/978-1-59745-451-3_7</pub-id></element-citation></ref>
<ref id="b16-mmr-21-06-2415"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2-&#x0394;&#x0394;CT method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b17-mmr-21-06-2415"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>BP</given-names></name><name><surname>Shih</surname><given-names>IH</given-names></name><name><surname>Jones-Rhoades</surname><given-names>MW</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name></person-group><article-title>Prediction of mammalian microRNA targets</article-title><source>Cell</source><volume>115</volume><fpage>787</fpage><lpage>798</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0092-8674(03)01018-3</pub-id><pub-id pub-id-type="pmid">14697198</pub-id></element-citation></ref>
<ref id="b18-mmr-21-06-2415"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><article-title>Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists</article-title><source>Nucleic Acids Res</source><volume>37</volume><fpage>1</fpage><lpage>13</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></element-citation></ref>
<ref id="b19-mmr-21-06-2415"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>M</given-names></name><name><surname>Horton</surname><given-names>JD</given-names></name><name><surname>Cohen</surname><given-names>JC</given-names></name><name><surname>Hobbs</surname><given-names>HH</given-names></name><name><surname>Stephens</surname><given-names>RM</given-names></name></person-group><article-title>WholePathwayScope: A comprehensive pathway-based analysis tool for high-throughput data</article-title><source>BMC Bioinformatics</source><volume>7</volume><fpage>30</fpage><year>2006</year><pub-id pub-id-type="doi">10.1186/1471-2105-7-30</pub-id><pub-id pub-id-type="pmid">16423281</pub-id><pub-id pub-id-type="pmcid">1388242</pub-id></element-citation></ref>
<ref id="b20-mmr-21-06-2415"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name><name><surname>Kawashima</surname><given-names>S</given-names></name><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name></person-group><article-title>The KEGG resource for deciphering the genome</article-title><source>Nucleic Acids Res</source><volume>32</volume><fpage>D277</fpage><lpage>D280</lpage><year>2004</year><pub-id pub-id-type="doi">10.1093/nar/gkh063</pub-id><pub-id pub-id-type="pmid">14681412</pub-id><pub-id pub-id-type="pmcid">308797</pub-id></element-citation></ref>
<ref id="b21-mmr-21-06-2415"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title><source>J R Stat Soc B</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><year>1995</year></element-citation></ref>
<ref id="b22-mmr-21-06-2415"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Fluid shear stress induces cell migration and invasion via activating autophagy in HepG2 cells</article-title><source>Cell Adhes Migr</source><volume>13</volume><fpage>152</fpage><lpage>163</lpage><year>2019</year><pub-id pub-id-type="doi">10.1080/19336918.2019.1568141</pub-id></element-citation></ref>
<ref id="b23-mmr-21-06-2415"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Fluid Shear Stress Promotes Autophagy in Hepatocellular Carcinoma Cells</article-title><source>Int J Biol Sci</source><volume>14</volume><fpage>1277</fpage><lpage>1290</lpage><year>2018</year><pub-id pub-id-type="doi">10.7150/ijbs.27055</pub-id><pub-id pub-id-type="pmid">30123076</pub-id><pub-id pub-id-type="pmcid">6097484</pub-id></element-citation></ref>
<ref id="b24-mmr-21-06-2415"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Waard</surname><given-names>V</given-names></name><name><surname>Arkenbout</surname><given-names>EK</given-names></name><name><surname>Vos</surname><given-names>M</given-names></name><name><surname>Mocking</surname><given-names>AI</given-names></name><name><surname>Niessen</surname><given-names>HW</given-names></name><name><surname>Stooker</surname><given-names>W</given-names></name><name><surname>de Mol</surname><given-names>BA</given-names></name><name><surname>Quax</surname><given-names>PH</given-names></name><name><surname>Bakker</surname><given-names>EN</given-names></name><name><surname>VanBavel</surname><given-names>E</given-names></name><etal/></person-group><article-title>TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells</article-title><source>Am J Pathol</source><volume>168</volume><fpage>2027</fpage><lpage>2035</lpage><year>2006</year><pub-id pub-id-type="doi">10.2353/ajpath.2006.050932</pub-id><pub-id pub-id-type="pmid">16723716</pub-id><pub-id pub-id-type="pmcid">1606614</pub-id></element-citation></ref>
<ref id="b25-mmr-21-06-2415"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyts</surname><given-names>FA</given-names></name><name><surname>Bosmans</surname><given-names>B</given-names></name><name><surname>Niesing</surname><given-names>R</given-names></name><name><surname>van Leeuwen</surname><given-names>JP</given-names></name><name><surname>Weinans</surname><given-names>H</given-names></name></person-group><article-title>Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation</article-title><source>Calcif Tissue Int</source><volume>72</volume><fpage>505</fpage><lpage>512</lpage><year>2003</year><pub-id pub-id-type="doi">10.1007/s00223-002-2027-0</pub-id><pub-id pub-id-type="pmid">12532282</pub-id></element-citation></ref>
<ref id="b26-mmr-21-06-2415"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Blume</surname><given-names>P</given-names></name><name><surname>Ohgi</surname><given-names>S</given-names></name><name><surname>Sumpio</surname><given-names>BE</given-names></name></person-group><article-title>The effect of different frequencies of stretch on human dermal keratinocyte proliferation and survival</article-title><source>J Surg Res</source><volume>155</volume><fpage>125</fpage><lpage>131</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.jss.2008.07.029</pub-id><pub-id pub-id-type="pmid">19059608</pub-id></element-citation></ref>
<ref id="b27-mmr-21-06-2415"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name></person-group><article-title>The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma</article-title><source>Ann Surg</source><volume>251</volume><fpage>1056</fpage><lpage>1063</lpage><year>2010</year><pub-id pub-id-type="doi">10.1097/SLA.0b013e3181dd4ea9</pub-id><pub-id pub-id-type="pmid">20485139</pub-id></element-citation></ref>
<ref id="b28-mmr-21-06-2415"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname><given-names>D</given-names></name><name><surname>de Carvalho</surname><given-names>AC</given-names></name><name><surname>Horst</surname><given-names>MA</given-names></name><name><surname>Carvalho</surname><given-names>AL</given-names></name><name><surname>Scapulatempo-Neto</surname><given-names>C</given-names></name><name><surname>Vettore</surname><given-names>AL</given-names></name></person-group><article-title>Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma</article-title><source>J Transl Med</source><volume>13</volume><fpage>262</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12967-015-0621-y</pub-id><pub-id pub-id-type="pmid">26264462</pub-id><pub-id pub-id-type="pmcid">4533949</pub-id></element-citation></ref>
<ref id="b29-mmr-21-06-2415"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaira</surname><given-names>V</given-names></name><name><surname>Faversani</surname><given-names>A</given-names></name><name><surname>Dohi</surname><given-names>T</given-names></name><name><surname>Montorsi</surname><given-names>M</given-names></name><name><surname>Augello</surname><given-names>C</given-names></name><name><surname>Gatti</surname><given-names>S</given-names></name><name><surname>Coggi</surname><given-names>G</given-names></name><name><surname>Altieri</surname><given-names>DC</given-names></name><name><surname>Bosari</surname><given-names>S</given-names></name></person-group><article-title>miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression</article-title><source>Oncogene</source><volume>31</volume><fpage>27</fpage><lpage>38</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/onc.2011.209</pub-id><pub-id pub-id-type="pmid">21643016</pub-id></element-citation></ref>
<ref id="b30-mmr-21-06-2415"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>AR</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Kaul</surname><given-names>Z</given-names></name><name><surname>Choi</surname><given-names>IK</given-names></name><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>JR</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><etal/></person-group><article-title>MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3&#x2032; untranslated region</article-title><source>Nucleic Acids Res</source><volume>39</volume><fpage>8078</fpage><lpage>8091</lpage><year>2011</year><pub-id pub-id-type="doi">10.1093/nar/gkr492</pub-id><pub-id pub-id-type="pmid">21724611</pub-id><pub-id pub-id-type="pmcid">3185413</pub-id></element-citation></ref>
<ref id="b31-mmr-21-06-2415"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migita</surname><given-names>K</given-names></name><name><surname>Komori</surname><given-names>A</given-names></name><name><surname>Kozuru</surname><given-names>H</given-names></name><name><surname>Jiuchi</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Yasunami</surname><given-names>M</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><name><surname>Abiru</surname><given-names>S</given-names></name><name><surname>Yamasaki</surname><given-names>K</given-names></name><name><surname>Nagaoka</surname><given-names>S</given-names></name><etal/></person-group><article-title>Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis</article-title><source>PLoS One</source><volume>10</volume><fpage>e0136908</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0136908</pub-id><pub-id pub-id-type="pmid">26575387</pub-id><pub-id pub-id-type="pmcid">4648542</pub-id></element-citation></ref>
<ref id="b32-mmr-21-06-2415"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polioudakis</surname><given-names>D</given-names></name><name><surname>Abell</surname><given-names>NS</given-names></name><name><surname>Iyer</surname><given-names>VR</given-names></name></person-group><article-title>miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing</article-title><source>BMC Genomics</source><volume>16</volume><fpage>40</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12864-015-1279-9</pub-id><pub-id pub-id-type="pmid">25653011</pub-id><pub-id pub-id-type="pmcid">4326481</pub-id></element-citation></ref>
<ref id="b33-mmr-21-06-2415"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jima</surname><given-names>DD</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>KL</given-names></name><name><surname>Dunphy</surname><given-names>CH</given-names></name><name><surname>Choi</surname><given-names>WW</given-names></name><name><surname>Au</surname><given-names>WY</given-names></name><name><surname>Srivastava</surname><given-names>G</given-names></name><name><surname>Czader</surname><given-names>MB</given-names></name><name><surname>Rizzieri</surname><given-names>DA</given-names></name><etal/><collab collab-type="corp-author">Hematologic Malignancies Research Consortium</collab></person-group><article-title>Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs</article-title><source>Blood</source><volume>116</volume><fpage>e118</fpage><lpage>e127</lpage><year>2010</year><pub-id pub-id-type="doi">10.1182/blood-2010-05-285403</pub-id><pub-id pub-id-type="pmid">20733160</pub-id><pub-id pub-id-type="pmcid">3012600</pub-id></element-citation></ref>
<ref id="b34-mmr-21-06-2415"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>GB</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name></person-group><article-title>MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells</article-title><source>Neoplasia</source><volume>21</volume><fpage>206</fpage><lpage>215</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.neo.2018.12.005</pub-id><pub-id pub-id-type="pmid">30622051</pub-id><pub-id pub-id-type="pmcid">6355618</pub-id></element-citation></ref>
<ref id="b35-mmr-21-06-2415"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>SP</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name></person-group><article-title>miR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of liver cancer through inhibiting WEE1</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>23</volume><fpage>2028</fpage><lpage>2037</lpage><year>2019</year><pub-id pub-id-type="pmid">30915746</pub-id></element-citation></ref>
<ref id="b36-mmr-21-06-2415"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>P</given-names></name></person-group><article-title>miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway</article-title><source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source><volume>33</volume><fpage>1360</fpage><lpage>1364</lpage><year>2017</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">29169421</pub-id></element-citation></ref>
<ref id="b37-mmr-21-06-2415"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowdy</surname><given-names>SC</given-names></name><name><surname>Mariani</surname><given-names>A</given-names></name><name><surname>Reinholz</surname><given-names>MM</given-names></name><name><surname>Keeney</surname><given-names>GL</given-names></name><name><surname>Spelsberg</surname><given-names>TC</given-names></name><name><surname>Podratz</surname><given-names>KC</given-names></name><name><surname>Janknecht</surname><given-names>R</given-names></name></person-group><article-title>Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer</article-title><source>Gynecol Oncol</source><volume>96</volume><fpage>368</fpage><lpage>373</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.ygyno.2004.10.006</pub-id><pub-id pub-id-type="pmid">15661223</pub-id></element-citation></ref>
<ref id="b38-mmr-21-06-2415"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleeff</surname><given-names>J</given-names></name><name><surname>Ishiwata</surname><given-names>T</given-names></name><name><surname>Maruyama</surname><given-names>H</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Truong</surname><given-names>P</given-names></name><name><surname>B&#x00FC;chler</surname><given-names>MW</given-names></name><name><surname>Falb</surname><given-names>D</given-names></name><name><surname>Korc</surname><given-names>M</given-names></name></person-group><article-title>The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer</article-title><source>Oncogene</source><volume>18</volume><fpage>5363</fpage><lpage>5372</lpage><year>1999</year><pub-id pub-id-type="doi">10.1038/sj.onc.1202909</pub-id><pub-id pub-id-type="pmid">10498890</pub-id></element-citation></ref>
<ref id="b39-mmr-21-06-2415"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>P</given-names></name><name><surname>Carvajal-Carmona</surname><given-names>L</given-names></name><name><surname>Pittman</surname><given-names>AM</given-names></name><name><surname>Webb</surname><given-names>E</given-names></name><name><surname>Howarth</surname><given-names>K</given-names></name><name><surname>Rowan</surname><given-names>A</given-names></name><name><surname>Lubbe</surname><given-names>S</given-names></name><name><surname>Spain</surname><given-names>S</given-names></name><name><surname>Sullivan</surname><given-names>K</given-names></name><name><surname>Fielding</surname><given-names>S</given-names></name><etal/><collab collab-type="corp-author">CORGI Consortium</collab></person-group><article-title>A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk</article-title><source>Nat Genet</source><volume>39</volume><fpage>1315</fpage><lpage>1317</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/ng.2007.18</pub-id><pub-id pub-id-type="pmid">17934461</pub-id></element-citation></ref>
<ref id="b40-mmr-21-06-2415"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>LK</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>ZS</given-names></name><name><surname>Zhao</surname><given-names>QY</given-names></name><name><surname>Wu</surname><given-names>LQ</given-names></name><name><surname>Qu</surname><given-names>ZQ</given-names></name></person-group><article-title>MicroRNA-92b promotes liver cancer progression by targeting Smad7 and is mediated by long non-coding RNA XIST</article-title><source>Cell Death Dis</source><volume>7</volume><fpage>e2203</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/cddis.2016.100</pub-id><pub-id pub-id-type="pmid">27100897</pub-id><pub-id pub-id-type="pmcid">4855645</pub-id></element-citation></ref>
<ref id="b41-mmr-21-06-2415"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>S</given-names></name></person-group><article-title>Long non-coding RNA SNAI3-AS1 promotes the proliferation and metastasis of liver cancer by regulating the UPF1/Smad7 signalling pathway</article-title><source>J Cell Mol Med</source><year>2019</year></element-citation></ref>
<ref id="b42-mmr-21-06-2415"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Francis</surname><given-names>R</given-names></name><name><surname>Pestell</surname><given-names>R</given-names></name></person-group><article-title>Cyclin-dependent kinase inhibitors: Novel anticancer agents</article-title><source>Expert Opin Investig Drugs</source><volume>9</volume><fpage>1849</fpage><lpage>1870</lpage><year>2000</year><pub-id pub-id-type="doi">10.1517/13543784.9.8.1849</pub-id><pub-id pub-id-type="pmid">11060782</pub-id></element-citation></ref>
<ref id="b43-mmr-21-06-2415"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>JY</given-names></name><name><surname>Richardson</surname><given-names>BC</given-names></name></person-group><article-title>The MAPK signalling pathways and colorectal cancer</article-title><source>Lancet Oncol</source><volume>6</volume><fpage>322</fpage><lpage>327</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/S1470-2045(05)70168-6</pub-id><pub-id pub-id-type="pmid">15863380</pub-id></element-citation></ref>
<ref id="b44-mmr-21-06-2415"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>EK</given-names></name><name><surname>Choi</surname><given-names>EJ</given-names></name></person-group><article-title>Pathological roles of MAPK signaling pathways in human diseases</article-title><source>Biochim Biophys Acta</source><volume>1802</volume><fpage>396</fpage><lpage>405</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bbadis.2009.12.009</pub-id><pub-id pub-id-type="pmid">20079433</pub-id></element-citation></ref>
<ref id="b45-mmr-21-06-2415"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ouyang</surname><given-names>XS</given-names></name><name><surname>Lee</surname><given-names>TK</given-names></name><name><surname>Fan</surname><given-names>TY</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Tsao</surname><given-names>SW</given-names></name><name><surname>Wong</surname><given-names>YC</given-names></name></person-group><article-title>Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth</article-title><source>Oncogene</source><volume>21</volume><fpage>8498</fpage><lpage>8505</lpage><year>2002</year><pub-id pub-id-type="doi">10.1038/sj.onc.1206007</pub-id><pub-id pub-id-type="pmid">12466969</pub-id></element-citation></ref>
<ref id="b46-mmr-21-06-2415"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fresno Vara</surname><given-names>JA</given-names></name><name><surname>Casado</surname><given-names>E</given-names></name><name><surname>de Castro</surname><given-names>J</given-names></name><name><surname>Cejas</surname><given-names>P</given-names></name><name><surname>Belda-Iniesta</surname><given-names>C</given-names></name><name><surname>Gonz&#x00E1;lez-Bar&#x00F3;n</surname><given-names>M</given-names></name></person-group><article-title>PI3K/Akt signalling pathway and cancer</article-title><source>Cancer Treat Rev</source><volume>30</volume><fpage>193</fpage><lpage>204</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.ctrv.2003.07.007</pub-id><pub-id pub-id-type="pmid">15023437</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-21-06-2415" position="float">
<label>Figure 1.</label>
<caption><p>Increase in cell adherence and growth using collagen coating. (A) Collagen-free coating (magnification, &#x00D7;100). (B) Collagen coating (magnification, &#x00D7;100).</p></caption>
<graphic xlink:href="MMR-21-06-2415-g00.tif"/>
</fig>
<fig id="f2-mmr-21-06-2415" position="float">
<label>Figure 2.</label>
<caption><p>Determination of the most suitable strain condition using flow cytometry. (A) Time group: (B) Compared with the control group without tension, the PI increased significantly in 24 h and 48 h groups. (C) Frequency group: (D) Compared with the control group without tension, the PI increased significantly in 1 Hz group. Determination of the most suitable strain condition using flow cytometry. (E) Amplitude group: (F) Compared with the control group without tension, the PI increased significantly in the 5 and 15&#x0025; groups. All the control groups were non-tension loaded groups. The data of PI are shown as the mean &#x00B1; SD from three wells/group. &#x002A;&#x002A;&#x002A;P&#x003C;0.001, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. control. PI, proliferation index.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g01.tif"/>
<graphic xlink:href="MMR-21-06-2415-g02.tif"/>
<graphic xlink:href="MMR-21-06-2415-g03.tif"/>
</fig>
<fig id="f3-mmr-21-06-2415" position="float">
<label>Figure 3.</label>
<caption><p>Measuring cell proliferation. (A) BrdU assay demonstrated that tensor strain promotes cell proliferation. The results showed that compared with the control group, the tensile strain amplitude of 15&#x0025; and the frequency of 1 Hz for 24 h significantly promoted the DNA synthesis of the cells. (B) CCK-8 assay indicated that tensor strain promotes cell proliferation. The results showed that compared with the control group, the tensile strain amplitude of 15&#x0025; and the frequency of 1 Hz for 24 h significantly promoted the DNA synthesis of the cells. &#x002A;&#x002A;&#x002A;P&#x003C;0.001, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. control. BrdU, 5-bromodeoxyuridine; CCK-8, Cell Counting Kit-8; OD, optical density.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g04.tif"/>
</fig>
<fig id="f4-mmr-21-06-2415" position="float">
<label>Figure 4.</label>
<caption><p>Changes in expression levels of seven miRNAs detected by RT-qPCR. Results of RT-qPCR are consistent with those of the miRNA microarray. &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. control. miR/miRNAs, microRNAs; RT-qPCR, reverse transcription-quantitative PCR.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g05.tif"/>
</fig>
<fig id="f5-mmr-21-06-2415" position="float">
<label>Figure 5.</label>
<caption><p>Results of database analysis. In order to remove the false results, the intersection of three databases were taken for 224 target genes.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g06.tif"/>
</fig>
<fig id="f6-mmr-21-06-2415" position="float">
<label>Figure 6.</label>
<caption><p>GO and KEGG analyses. GO analysis based on miRNA-targeted genes using three databases: (A) &#x2018;Cellular component&#x2019; category; and (B) &#x2018;molecular function&#x2019; category. GO and KEGG analyses. GO analysis based on miRNA-targeted genes using three databases: (C) &#x2018;Biological process&#x2019; category. (D) Pathway analysis based on miRNA-targeted genes using KEGG. miRNA, microRNA; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology; FDR-bh, Benjamini-Hochberg false discovery rate.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g07.tif"/>
<graphic xlink:href="MMR-21-06-2415-g08.tif"/>
</fig>
<fig id="f7-mmr-21-06-2415" position="float">
<label>Figure 7.</label>
<caption><p>BrdU assay results on proliferative ability of HepG2 cells and normal hepatocyte HL-7702 cells. The proliferation ability of HL-7702 cells was not significantly altered after being coated by strain, but that of HepG2 cells was increased. &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. control.</p></caption>
<graphic xlink:href="MMR-21-06-2415-g09.tif"/>
</fig>
<table-wrap id="tI-mmr-21-06-2415" position="float">
<label>Table I.</label>
<caption><p>Primer design.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Gene name</th>
<th align="center" valign="bottom">Primer sequence (5&#x2032;&#x2192;3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">hsa-miR-7845-5p</td>
<td align="left" valign="top">F: GCGAAGGGACAGGGAGGG</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCACGA</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6889-5p</td>
<td align="left" valign="top">F: GTCGGGGAGTCTGGGGTC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACATTCCG</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6794-5p</td>
<td align="left" valign="top">F: CGCAGGGGGACTGGGG</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGCTCAC</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6752-5p</td>
<td align="left" valign="top">F: GGGGGGTGTGGAGCCA</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGCCCCC</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-503-5p</td>
<td align="left" valign="top">F: CGTAGCAGCGGGAACAGTT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTGCAG</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-4428</td>
<td align="left" valign="top">F: CGCAAGGAGACGGGAACA</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGCTCCA</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-296-5p</td>
<td align="left" valign="top">F: GAGGGCCCCCCCTCAA</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: AGTGCAGGGTCCGAGGTATT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGGA</td>
</tr>
<tr>
<td align="left" valign="top">U6</td>
<td align="left" valign="top">F: GCTTCGGCAGCACATATACTAAAAT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: CGCTTCACGAATTTGCGTGTCAT</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">RT primer: CGCTTCACGAATTTGCGTGTCAT</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-21-06-2415"><p>F, forward; R, reverse; miR, microRNA; RT, reverse transcription.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-mmr-21-06-2415" position="float">
<label>Table II.</label>
<caption><p>Differentially expressed miRNAs.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">miRNA</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">Regulation</th>
<th align="center" valign="bottom">FC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">hsa-miR-296-5p</td>
<td align="left" valign="top">0.00094</td>
<td align="center" valign="top">up</td>
<td align="center" valign="top">6.387268</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-4428</td>
<td align="left" valign="top">0.015763873</td>
<td align="center" valign="top">down</td>
<td align="center" valign="top">&#x2212;2.8974507</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-503-5p</td>
<td align="left" valign="top">0.043706737</td>
<td align="center" valign="top">down</td>
<td align="center" valign="top">&#x2212;4.2659197</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6752-5p</td>
<td align="left" valign="top">0.015388427</td>
<td align="center" valign="top">up</td>
<td align="center" valign="top">9.723028</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6794-5p</td>
<td align="left" valign="top">0.000131</td>
<td align="center" valign="top">up</td>
<td align="center" valign="top">20.911135</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6889-5p</td>
<td align="left" valign="top">0.027508989</td>
<td align="center" valign="top">up</td>
<td align="center" valign="top">11.433076</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-7845-5p</td>
<td align="left" valign="top">0.000946</td>
<td align="center" valign="top">up</td>
<td align="center" valign="top">9.37658</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-mmr-21-06-2415"><p>miRNA/miR, microRNA.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-mmr-21-06-2415" position="float">
<label>Table III.</label>
<caption><p>Predictive target genes for differentially expressed miRNAs.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">miRNA</th>
<th align="center" valign="bottom">Predictive target genes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">hsa-miR-296-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2,613</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-4428</td>
<td align="center" valign="top">&#x00A0;&#x00A0;3,043</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6752-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2,572</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6794-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2,521</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-6889-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;1,279</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-7845-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2,327</td>
</tr>
<tr>
<td align="left" valign="top">hsa-miR-503-5p</td>
<td align="center" valign="top">&#x00A0;&#x00A0;1,850</td>
</tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="center" valign="top">16,205</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-mmr-21-06-2415"><p>miR/miRNA, microRNA.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>